Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nutr.

Sec. Clinical Nutrition

This article is part of the Research TopicNutrition in Pancreatic Diseases: The Role of Nutritional Status and Nutrition Therapy in the Management of Pancreatitis and Pancreatic CancerView all 9 articles

Early enteral nutrition combined with supplemental parenteral nutrition versus total parenteral nutrition after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis of postoperative complications

Provisionally accepted
Jialing  LiJialing Li1,2*Defu  HuDefu Hu2Jianjie  ShengJianjie Sheng2Zhiang  WangZhiang Wang2Hexing  HangHexing Hang3,4Yudong  QiuYudong Qiu2,3Dayu  ChenDayu Chen5*旭  伏旭 伏3*
  • 1Nanjing Drum Tower Hospital, Nanjing, China
  • 2Department of Pancreatic and metabolic surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China, Department of Pancreatic and metabolic surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China, China
  • 3Department of Pancreatic and metabolic surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., Department of Pancreatic and metabolic surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China., China
  • 4Department of Pathology, Nanjing Drum Tower Hospital, Nanjing, Liaoning Province, China
  • 5Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu Province, China

The final, formatted version of the article will be published soon.

Background: Postoperative nutritional support strategy after pancreaticoduodenectomy (PD) remains controversial. This retrospective study aims to evaluate early enteral nutrition (EEN) combined with supplemental parenteral nutrition (SPN) and parenteral nutrition (PN) as postoperative nutrition support on early clinical outcomes and postoperative complications in patients who underwent PD. Methods: Clinical data from consecutive patients who underwent PD between January 2022 and July 2024 were collected and analyzed in this retrospective study. The primary outcome was the incidence of postoperative complications. The secondary outcomes encompassed a comparison of postoperative complications between the two groups, including delayed gastric emptying (DGE), bile leak (BL), chyle leak (CL), acute pancreatitis (AP), postpancreatectomy hemorrhage (PPH), and infectious complications. A propensity score-matched (PSM) analysis was performed to balance baseline confounders between the two groups. Results: According to perioperative nutritional protocols, 248 patients were finally included and divided into EEN+SPN group (n=116) and PN group (n=132). After PSM, baseline characteristics were balanced between the EEN+SPN group (n=59) and PN group (n=59). No statistically significant differences were observed in the incidence of complications between the two groups, either before or after PSM (all P>0.05). Befor PSM, the overall incidence of severe postoperative complications was 10.1%. The EEN+SPN group demonstrated a significantly lower incidence of severe complications compared to the PN group both before and after PSM (P<0.05). Analysis of secondary outcomes (which included a comparative analysis of detailed complications) revealed no significant differences between the groups. Conclusion: In conclusion, this study demonstrates that for patients at nutritional risk following PD, EEN+SPN is a safe and feasible nutritional support strategy and is associated with a significant reduction in the incidence of severe complications.

Keywords: Pancreaticoduodenectomy, Nutritional support strategy, severe complications, Early enteral nutrition, Supplemental parenteral nutrition

Received: 05 Apr 2025; Accepted: 06 Nov 2025.

Copyright: © 2025 Li, Hu, Sheng, Wang, Hang, Qiu, Chen and 伏. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jialing Li, 13951498518@163.com
Dayu Chen, cdy_pharmacy@njglyy.com
旭 伏, fuxunju2012@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.